搜索临床试验以:替雷利珠单抗加呋喹替尼和 SBRT
总计4676个结果
-
Huazhong University of Science and Technology主动,不招人
-
InBios International, Inc.Biomedical Advanced Research and Development Authority; Fast-Track Drugs & Biologics, LLC完全的
-
Bern University of Applied Sciences完全的
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Splendor-NC招聘中
-
Peking University Cancer Hospital & Institute招聘中
-
Bern University of Applied SciencesGoethe University; Maastricht University Medical Center; Swiss Federal Institute of Technology完全的
-
George Washington UniversityPatient-Centered Outcomes Research Institute; University of Bristol; West Virginia University...尚未招聘
-
Bern University of Applied SciencesGoethe University; Maastricht University Medical Center; Swiss Federal Institute of Technology完全的
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Nanchang University; Chinese PLA General Hospital; The Affiliated... 和其他合作者招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
University of MalayaTeleflex招聘中
-
BeiGene完全的
-
Hutchison Medipharma LimitedBeiGene主动,不招人
-
Juravinski Cancer CenterHamilton Health Sciences Corporation; Juravinski Cancer Centre Foundation未知
-
Nanfang Hospital, Southern Medical University招聘中
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫疗法 | 生存结果 | 免疫检查点抑制剂 | 客观反应率 | 转移性宫颈癌 | 替雷利珠单抗 | 持续性宫颈癌 | 抗程序性细胞死亡受体 1中国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘
-
Peking University招聘中
-
Guangxi Medical University尚未招聘
-
Sun Yat-sen University尚未招聘肝细胞癌 | 免疫疗法 | 二线治疗 | 抗血管生成治疗 | FOLFOX全身化疗
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health and Social... 和其他合作者未知
-
Cancer Institute and Hospital, Chinese Academy...招聘中